BAJAJHCARE
Bajaj Healthcare Limited (BAJAJHCARE) Stock Analysis
Bajaj Healthcare Limited is an Indian pharmaceutical company manufacturing APIs and formulations. It produces active pharmaceutical ingredients and finished dosages for regulated and domestic markets. The company has grown through acquisitions in the API space. It is a listed pharma mid-cap stock.
Healthcare › Drug Manufacturers - Specialty & Generic
₹320.00
-0.91% 1W | -32.80% 52W
Market Cap
1.1k CR
P/E Ratio
46.2
52W High
₹490
52W Low
₹272.4
Div. Yield
0.48%
Beta
0.3
50 DMA
₹329.2
200 DMA
₹330.8
Profit Margin
2.8%
Inst. Own.
1.9%
✅ BOUNCE FROM SUPPORT
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 101 | 109 | 134 | 132 | 133 | 123 | 154 | 149 | 148 | 161 | 153 | 166 |
| Expenses | 108 | 82 | 89 | 118 | 108 | 109 | 101 | 143 | 124 | 121 | 131 | 130 | 137 |
| Operating Profit | 22 | 19 | 20 | 16 | 24 | 25 | 22 | 12 | 25 | 27 | 31 | 23 | 29 |
| OPM % | 17% | 19% | 18% | 12% | 19% | 18% | 18% | 8% | 16% | 18% | 19% | 15% | 17% |
| Other Income | -55 | -7 | -7 | -36 | -0 | 4 | -1 | 13 | 1 | 0 | 1 | -34 | 1 |
| Interest | 9 | 8 | 7 | 6 | 8 | 8 | 6 | 6 | 5 | 6 | 6 | 6 | 6 |
| Depreciation | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 6 | 7 | 7 | 8 | 7 |
| Profit before tax | -48 | -3 | -1 | -33 | 9 | 14 | 8 | 11 | 14 | 15 | 19 | -24 | 16 |
| Tax % | -0% | 4% | 58% | -10% | 23% | 30% | -39% | 1% | 17% | 24% | 17% | -6% | 16% |
| Net Profit | -48 | -3 | -2 | -30 | 7 | 9 | 12 | 11 | 12 | 11 | 16 | -23 | 14 |
| EPS in Rs | -17.47 | -1.25 | -0.80 | -10.84 | 2.58 | 3.00 | 3.71 | 3.54 | 3.75 | 3.52 | 4.96 | -6.79 | 4.07 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 218 | 223 | 231 | 327 | 370 | 410 | 657 | 680 | 646 | 473 | 543 | 611 | 628 |
| Expenses | 189 | 193 | 200 | 288 | 327 | 362 | 521 | 561 | 534 | 397 | 460 | 506 | 519 |
| Operating Profit | 29 | 30 | 31 | 39 | 43 | 48 | 136 | 119 | 112 | 76 | 83 | 105 | 109 |
| OPM % | 13% | 14% | 13% | 12% | 12% | 12% | 21% | 17% | 17% | 16% | 15% | 17% | 17% |
| Other Income | 0 | 0 | 2 | 2 | 1 | 7 | 7 | 1 | -19 | -105 | 16 | -32 | -32 |
| Interest | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 13 | 18 | 30 | 28 | 22 | 23 |
| Depreciation | 9 | 9 | 11 | 11 | 11 | 12 | 16 | 18 | 17 | 28 | 28 | 28 | 29 |
| Profit before tax | 12 | 14 | 14 | 23 | 24 | 36 | 119 | 90 | 58 | -86 | 43 | 23 | 25 |
| Tax % | 37% | 39% | 43% | 33% | 33% | 30% | 30% | 20% | 25% | -3% | 7% | 33% | |
| Net Profit | 8 | 8 | 8 | 15 | 16 | 25 | 83 | 71 | 43 | -84 | 40 | 16 | 18 |
| EPS in Rs | 8.34 | 3.04 | 2.83 | 5.50 | 5.91 | 9.14 | 30.11 | 25.87 | 15.59 | -30.36 | 12.51 | 4.68 | 5.76 |
| Dividend Payout % | 0% | 0% | 0% | 5% | 0% | 0% | 5% | 6% | 6% | -3% | 8% | 32% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -2.0% | -1.0% | 11.0% |
| Profit CAGR | -1.0% | -13.0% | 17.0% |
Shareholding Pattern
Promoters59.19%
FIIs1.09%
DIIs3.16%
Public36.56%
Promoters59.19%
FIIs1.12%
DIIs2.99%
Public36.70%
Promoters59.19%
FIIs1.18%
DIIs2.96%
Public36.67%
Promoters58.29%
FIIs1.98%
DIIs2.91%
Public36.82%
Promoters58.59%
FIIs2.19%
DIIs1.92%
Public37.30%
Promoters67.49%
FIIs0.78%
DIIs0.34%
Public31.38%
Promoters67.74%
FIIs0.53%
DIIs0.43%
Public31.31%
Promoters59.19%
FIIs1.05%
DIIs2.52%
Public37.25%
Promoters58.29%
FIIs1.98%
DIIs2.91%
Public36.82%
Promoters58.59%
FIIs2.19%
DIIs1.92%
Public37.30%
BAJAJHCARE
Holdings Analysis
Key strengths & risk signals
44
Overall
36
Fundamental
52
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 32.8% in the last year.
WEAK POSITION! Current price (320.0) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.9% (1 week), 4.1% (1 month), 8.2% (3 months).
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
TESTING SUPPORT! Stock is at key support level.
BULLISH SENTIMENT! In last 30 days: 14 up days, 15 down days. Avg volume on up days: 149,901 vs down days: 136,454. Ratio: 1.1x
Fundamental & Technical Analysis
44Overall
36Fundamental
52Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -1.8% (DECLINING, 2/15). Profit CAGR: -28.4% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 2.8% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.48% yield - little to no income.
Debt to Equity
8/10
LOW DEBT! D/E of 0.48 - strong balance sheet.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 31.48% public ownership - moderate retail influence.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (329.2) is below 200-day average (330.8) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (320.0) is below both moving averages.
Trend Pattern
16/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 32.8% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 15 down days. Avg volume on up days: 149,901 vs down days: 136,454. Ratio: 1.1x
RSI
3/5
NEUTRAL! RSI at 43.3 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 21.9% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.9% (1 week), 4.1% (1 month), 8.2% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
BAJAJHCARE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-07-27 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BAJAJHCARE | ₹320.00 | 46.2 | 2.8% | -1.8% | -28.4% | -32.8% | 44 | BOUNCE FROM SUPPORT | +16.1% | -159.8% | +11.3% | +8.2% |
| LINCOLN | ₹558.30 | 11.6 | 13.9% | 9.5% | 6.4% | +6.6% | 57 | BREAKDOWN | +30.7% | +212.1% | +15.1% | -5.3% |
| SIGACHI | ₹28.50 | 42.6 | 5.4% | 16.5% | – | -24.4% | 56 | BREAKDOWN | -106.8% | -11.7% | -5.4% | -0.5% |
| THEMISMED | ₹108.60 | 25.1 | 12.1% | -0.4% | -72.8% | -16.1% | 53 | BREAKDOWN | -273.2% | +176.4% | -10.9% | +13.7% |
| BAFNAPH | ₹418.00 | 127.1 | 5.5% | 9.3% | -0.7% | +152.4% | 66 | BREAKOUT | -97.1% | -96.3% | -23.1% | -37.0% |
| KILITCH | ₹241.60 | 27.4 | 12.7% | 19.2% | 42.4% | +41.9% | 84 | BREAKOUT | -3.3% | -80.0% | +4.2% | -49.9% |
| ANUHPHR | ₹82.00 | 18.6 | 5.7% | 13.5% | 4.3% | +4.0% | 64 | BREAKDOWN | +37.3% | -2.6% | +3.9% | -4.1% |
| ZIMLAB | ₹150.50 | 183.5 | 0.9% | -2.5% | -37.9% | +105.9% | 57 | APPROACHING RESISTANCE | +110.5% | -208.1% | +31.2% | -10.5% |
Data from TradeAlone · Updated daily
BAJAJHCARE News
